328 related articles for article (PubMed ID: 15951738)
21. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
[TBL] [Abstract][Full Text] [Related]
22. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
23. Variable oxygen and retinal VEGF levels: correlation with incidence and severity of pathology in a rat model of oxygen-induced retinopathy.
Werdich XQ; McCollum GW; Rajaratnam VS; Penn JS
Exp Eye Res; 2004 Nov; 79(5):623-30. PubMed ID: 15500821
[TBL] [Abstract][Full Text] [Related]
24. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
[TBL] [Abstract][Full Text] [Related]
25. [Expression of vascular endothelial growth factor and its receptor in experimental choroidal neovascularization in rat].
Zhao SH; He SZ; Shi XH
Zhonghua Yan Ke Za Zhi; 2004 Aug; 40(8):522-7. PubMed ID: 15454039
[TBL] [Abstract][Full Text] [Related]
26. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA
Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314
[TBL] [Abstract][Full Text] [Related]
27. Pentoxifylline inhibition of vasculogenesis in the neonatal rat retina.
Hasebe Y; Thomson LR; Dorey CK
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2774-8. PubMed ID: 10937597
[TBL] [Abstract][Full Text] [Related]
28. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
Kang S; Roh CR; Cho WK; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Curr Eye Res; 2013 Jan; 38(1):119-27. PubMed ID: 23013553
[TBL] [Abstract][Full Text] [Related]
30. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC
J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072
[TBL] [Abstract][Full Text] [Related]
31. Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model.
Takahashi H; Ishizaki H; Tahara H; Tamaki Y; Yanagi Y
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2143-7. PubMed ID: 18436847
[TBL] [Abstract][Full Text] [Related]
32. Effect of pitavastatin on experimental choroidal neovascularization in rats.
Sagara N; Kawaji T; Takano A; Inomata Y; Inatani M; Fukushima M; Tanihara H
Exp Eye Res; 2007 Jun; 84(6):1074-80. PubMed ID: 17418120
[TBL] [Abstract][Full Text] [Related]
33. Systemic rapamycin inhibits retinal and choroidal neovascularization in mice.
Dejneka NS; Kuroki AM; Fosnot J; Tang W; Tolentino MJ; Bennett J
Mol Vis; 2004 Dec; 10():964-72. PubMed ID: 15623986
[TBL] [Abstract][Full Text] [Related]
34. Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.
Santulli RJ; Kinney WA; Ghosh S; Decorte BL; Liu L; Tuman RW; Zhou Z; Huebert N; Bursell SE; Clermont AC; Grant MB; Shaw LC; Mousa SA; Galemmo RA; Johnson DL; Maryanoff BE; Damiano BP
J Pharmacol Exp Ther; 2008 Mar; 324(3):894-901. PubMed ID: 18083913
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.
Barnett JM; McCollum GW; Fowler JA; Duan JJ; Kay JD; Liu RQ; Bingaman DP; Penn JS
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):907-15. PubMed ID: 17251494
[TBL] [Abstract][Full Text] [Related]
36. Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo.
Yoo MH; Hyun HJ; Koh JY; Yoon YH
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4780-7. PubMed ID: 16303979
[TBL] [Abstract][Full Text] [Related]
37. The role of estrogen and estrogen receptorbeta in choroidal neovascularization.
Tanemura M; Miyamoto N; Mandai M; Kamizuru H; Ooto S; Yasukawa T; Takahashi M; Honda Y
Mol Vis; 2004 Dec; 10():923-32. PubMed ID: 15616479
[TBL] [Abstract][Full Text] [Related]
38. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.
Leske DA; Wu J; Fautsch MP; Karger RA; Berdahl JP; Lanier WL; Holmes JM
Mol Vis; 2004 Jan; 10():43-50. PubMed ID: 14758338
[TBL] [Abstract][Full Text] [Related]
39. Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat.
Takehana Y; Kurokawa T; Kitamura T; Tsukahara Y; Akahane S; Kitazawa M; Yoshimura N
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):459-66. PubMed ID: 9950606
[TBL] [Abstract][Full Text] [Related]
40. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats.
Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W
Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
